Medidata Solutions and Chiltern Announce ASPire to Win Partnership.International Contract Research Organization to Implement Leading EDC EDC See: Export Development Corp. Solution and Meet Growing Demand for Medidata Rave NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of and LONDON -- Medidata Solutions, a global provider of electronic clinical data capture (EDC), management and reporting solutions, today announced that Chiltern Ltd, a full service contract research organization (CRO), has signed as a partner through Medidata's ASPire to aspire to verb aim for, desire, pursue, hope for, long for, crave, seek out, wish for, dream about, yearn for, hunger for, hanker after, be eager for, set your heart on, set your sights on, be ambitious for Win[TM] Program. With this partnership, Medidata will provide the tools and training that will enable Chiltern to implement Medidata Rave[R] to manage the company's global Phase I-IV clinical development and late phase programs. As an early adopter of EDC, Chiltern provides necessary technical project management, team training and site level training in support of EDC implementation and adoption. Chiltern's dedicated EDC services to sponsors range from pilot programs to support of enterprise-level implementation. The company is looking to expand its service offerings, and after a review of the leading EDC vendors, Chiltern selected Medidata Rave. "We selected Medidata Rave since it is a leading EDC solution for ease of use and implementation. Rave has received an outstanding response from our users," said Glenn Kerkhof, Chiltern's Chief Executive Officer. "We felt Medidata was an ideal partner because of our common commitment to quality and compliance to regulatory expectations, globally." Medidata's ASPire to Win Program is a non-exclusive application service provider (ASP) partnership and business model. The program will allow Chiltern to meet sponsor demand for Medidata Rave and offer the platform in-house. As a result, Chiltern will be able to create new services revenue around the implementation of this industry-leading technology. Chiltern will leverage Medidata's ASPire to Win Program to build on the company's established presence as an EDC provider. The Rave certification will allow Chiltern's EDC Solutions Group to continue to expand their offerings for sponsors. This group currently provides advice and support for all EDC trials within Chiltern and assists with site and sponsor training as needed as needed prn. See prn order. . "Along with a progressive view of clinical technology, Chiltern has an impressive client base and a broad global reach," said Tarek Sherif she·rif also sha·rif n. 1. A descendant of the prophet Muhammad through his daughter Fatima. 2. The chief magistrate of Mecca in Ottoman times. 3. A Moroccan prince or ruler. , CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Medidata Solutions. "Through our ASPire to Win Program, Chiltern will be able to quickly realize the benefits and ROI (Return On Investment) The monetary benefits derived from having spent money on developing or revising a system. In the IT world, there are more ways to compute ROI than Carter has liver pills (and for those of you who never heard of that expression, it means a lot). that Medidata Rave brings and build upon its existing position in the CRO market." About Chiltern Established in 1982, Chiltern is a leading global contract research organization with extensive experience of running and staffing international Phase I to Phase IV clinical trials Noun 1. phase IV clinical trial - sometimes the FDA approves a drug for general use but requires the manufacturer to continue to monitor its effects; during this phase the drug may be tried on slightly different patient populations than those studied in earlier across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 1000 people with 18 offices across the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Europe and India. Chiltern provides development services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs Regulatory Affairs (RA), also called Government Affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, and banking. Regulatory Affairs professionals usually have responsibility for the following general areas: About Medidata Solutions Worldwide Medidata Solutions helps the world's leading pharmaceutical, biotechnology, medical device and research organizations maximize the value of their clinical research investments. Innovative process design, technology and services streamline clinical trials by providing early visibility to reliable clinical data - the lifeblood of every research organization. Working with companies and institutions both large and small, Medidata Solutions helps clinical researchers safely accelerate the process of bringing life-enhancing treatments to market - on six continents Six Continents is a large retail PLC in UK which split into Six Continents Retail known as Mitchells and Butlers plc. The hotels and soft drinks business of Six Continents PLC is now known as InterContinental Hotels Group PLC. and in more than 80 countries. Medidata Solutions brings significant value to its broad client base with deep clinical experience and expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. For more information, please visit www.mdsol.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion